Thu, October 20, 2011
[ Thu, Oct 20th 2011 ]: Market Wire
Australian Federal Government Grant to Study Effect of PBT2 in the Ageing Brain
[ Thu, Oct 20th 2011 ]: Market Wire
Allon Therapeutics Announces Completion of Patient Enrollment in Pivotal Trial
[ Thu, Oct 20th 2011 ]: Market Wire
Unigene Completes All Patient Dosing in Phase 2 S .. Treatment of Osteoporosis in Postmenopausal Women
[ Thu, Oct 20th 2011 ]: Market Wire
Interim Phase IIb Data for Merck's VICTRELISa" (b .. cted with Chronic Hepatitis C and HIV-1 Presented
[ Thu, Oct 20th 2011 ]: Market Wire
Synta to Host Third-Quarter 2011 Conference Call on November 3
[ Thu, Oct 20th 2011 ]: Market Wire
POZEN Announces November 3, 2011 Webcast of Third Quarter 2011 Results
[ Thu, Oct 20th 2011 ]: Market Wire
Cubist to Feature Antibiotic Development Programs at 49th IDSA
[ Thu, Oct 20th 2011 ]: Market Wire
Geron Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial
[ Thu, Oct 20th 2011 ]: Market Wire
Cambridge Heart Announces Initial Results of OEM Module Marketing Promotion
[ Thu, Oct 20th 2011 ]: Market Wire
Manchester Heart Centre in United Kingdom Obtains VMS(TM) Heart Analysis System
[ Thu, Oct 20th 2011 ]: Market Wire
Covidien Releases Clinical Data from Largest Pros .. Plaque Excision for Treatment of Peripheral Arter
[ Thu, Oct 20th 2011 ]: Market Wire
Five Star Quality Care, Inc. Third Quarter Conference Call Scheduled for Thursday, October 27th
[ Thu, Oct 20th 2011 ]: Market Wire
Capital Senior Living Corporation Closes Three Community $30 Million Acquisition
[ Thu, Oct 20th 2011 ]: Market Wire
Syneron kndigt weltweite Einfhrung einer neuen Ko .. echnologien fr die Gesichtsbehandlung mit dem eTw
[ Thu, Oct 20th 2011 ]: Market Wire
Device Master File for OncoSec Medical System Completed and Submitted to FDA
[ Thu, Oct 20th 2011 ]: Market Wire
Comprehensive Care Corporation CEO Clark A. Marcus Praised for U.S. Chamber of Commerce Service
Wed, October 19, 2011
[ Wed, Oct 19th 2011 ]: Market Wire
Bio-Path Holdings to Present at the 10th Annual BIO Investor Forum
[ Wed, Oct 19th 2011 ]: Market Wire
Theratechnologies Announces Application for Registration of Tesamorelin in Mexico
[ Wed, Oct 19th 2011 ]: Market Wire
Diligent Board Member Services Ranked Number 156 .. rth America on Deloitte's 2011 Technology Fast 50
[ Wed, Oct 19th 2011 ]: Market Wire
Universal American Corp. Schedules 2011 Third Qua .. nesday, October 26th and Conference Call on Thurs
[ Wed, Oct 19th 2011 ]: Market Wire
Marina Biotech Demonstrates In Vivo Dose-Dependen .. erability With a CRN-Substituted miRNA Antagonist
[ Wed, Oct 19th 2011 ]: Market Wire
Ardea Biosciences to Present Data From Gout Program at the 2011 ACR/ARHP Annual Scientific Meeting
[ Wed, Oct 19th 2011 ]: Market Wire
OPKO Health Subsidiary Receives Wall Street Journal 2011 Technology Innovation Award
[ Wed, Oct 19th 2011 ]: Market Wire
InSite Vision to Report Third Quarter 2011 Financial Results on October 27, 2011
[ Wed, Oct 19th 2011 ]: Market Wire
UNITEDHEALTHCARE OFRECE AUDFONOS SIN COSTO DE DES .. PARA LOS BENEFICIARIOS DEL CONDADO DE MIAMI-DADE
[ Wed, Oct 19th 2011 ]: Market Wire
Vertex Submits Application for Priority Review an .. 770, ivacaftor) in the U.S. as First Potential Me
[ Wed, Oct 19th 2011 ]: Market Wire
Ligand Enters into Platform Captisol® License Agreement with SAGE Therapeutics
[ Wed, Oct 19th 2011 ]: Market Wire
Single Pharmaceutical-Based Strategy Aims to Solve Neurological and Psychiatric Disorders
[ Wed, Oct 19th 2011 ]: Market Wire
Daten ber Vorteile frhzeitiger bzw. langfristiger .. f 5. dreijhrlichem gemeinsamem Kongress von ECTRI
[ Wed, Oct 19th 2011 ]: Market Wire
Astex Pharmaceuticals to Present at BIO Investor Forum on October 26th
[ Wed, Oct 19th 2011 ]: Market Wire
Presentati al 5o congresso triennale congiunto di .. ivi alla?uso precoce e ai vantaggi a lungo termin
Tue, October 18, 2011
[ Tue, Oct 18th 2011 ]: Market Wire
Allon Therapeutics Completes Equity Offering
[ Tue, Oct 18th 2011 ]: Market Wire
Standard &;; Poor's Initiates Stock Report Coverage on RepliCel Life Sciences Inc.
[ Tue, Oct 18th 2011 ]: Market Wire
Wright Medical Group, Inc. Names Julie D. Tracy S .. r Vice President and Chief Communications Officer
[ Tue, Oct 18th 2011 ]: Market Wire
Flamel Technologies Announces Multi-Year Supply A .. ith GlaxoSmithKline for Coreg CRa" Microparticles
[ Tue, Oct 18th 2011 ]: Market Wire
Biomerica Reports First Quarter Revenue Growth of 19.5%
[ Tue, Oct 18th 2011 ]: Market Wire
Micro Imaging Technology Introduces the MIT 1000A and a Family of Bacteria Identifying Software
[ Tue, Oct 18th 2011 ]: Market Wire
AVI BioPharma Announces Data Presentation for RNA .. rophy Drug Candidate at the 16th International Wo
[ Tue, Oct 18th 2011 ]: Market Wire
MethylGene Receives FDA IND Approval to Begin a P .. ith MGCD290, a Novel Antifungal Product Candidate
[ Tue, Oct 18th 2011 ]: Market Wire
Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2011 Financial Results
[ Tue, Oct 18th 2011 ]: Market Wire
ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results
[ Tue, Oct 18th 2011 ]: Market Wire
Given Imaging Announces New Study Shows Impact of .. lCam(R) SB on Management of Symptomatic IBD Cases
[ Tue, Oct 18th 2011 ]: Market Wire
Dr. Roberto Romero, NIH Principal Investigator of .. by Columbia Laboratories, Honored with John Ding
[ Tue, Oct 18th 2011 ]: Market Wire
Reflect Scientific, Inc. Introduces Cryometrix Model B-120 Blast Freezer
[ Tue, Oct 18th 2011 ]: Market Wire
Greystone Logistics Announces Preliminary Financial Results for 1st Quarter
[ Tue, Oct 18th 2011 ]: Market Wire
DaVita Announces Estimate of Third Quarter 2011 Results
Mon, October 17, 2011
[ Mon, Oct 17th 2011 ]: Market Wire
Afexa Announces Take-Up of Shares Under Valeant Offer
[ Mon, Oct 17th 2011 ]: Market Wire
NanoViricides Inc. Announces that its President Dr. Diwan has Completed his Stock Sales Program

Los datos sobre el uso temprano y los beneficios a largo plazo de TYSABRI han sido presentados en el 5 congreso trienal conjun

WESTON, Massachussets & DUBLIN--([ BUSINESS WIRE ])--[ Biogen Idec ] (NASDAQ: BIIB) y [ Elan Corporation, plc ](NYSE: ELN) han anunciado las 28 presentaciones de la empresa sobre TYSABRI? (natalizumab) durante el 5? congreso trienal conjunto de los comit?s europeos y americanos para el tratamiento e investigaci?n de la esclerosis m?ltiple (ECTRIMS y ACTRIMS), celebrado en ?msterdam (Holanda).

El comunicado en el idioma original, es la versi?n oficial y autorizada del mismo. La traducci?n es solamente un medio de ayuda y?deber? ser?comparada con el texto en idioma original, que es la ?nica versi?n del texto que tendr? validez legal.